What does research tell us about how DMTs affect the body’s immune response to COVID-19 vaccines?
Discover how MS organisations collaborate to translate vital MS information.
Six months into the COVID-19 Response Initiative
Researchers in Israel have published the results of a small study exploring how well the Pfizer-BioNtech COVID-19 vaccine protects people with MS taking cladribine, fingolimod or ocrelizumab.
Could a vaccine treat MS?
MSIF grants over £500,000 to MS organisations to help them through the pandemic.
A look back at what the global MS movement has achieved during the pandemic.
Updated global advice for people with MS and the data behind it
The COVID-19 pandemic has brought unprecedented challenges to MS organisations across the world, and the Associação Brasileira de Esclerose Múltipla (ABEM) in Brazil is no exception.
Register now: a webinar for people with MS and MS organisations – your questions answered on the COVID-19 & MS global data sharing initiative
Sharing data to find answers quicker during COVID-19
A message from the CEO of the MS International Federation as the global MS community faces the challenges of the coronavirus
Advice for people with MS - updated on 13 October